Drivers traveling from Germany to Poland should be aware of the stark differences in cannabis laws between the two countries. In Germany, a new law allows a maximum THC limit of 3.5 nanograms per milliliter of blood for drivers, equivalent to a blood alcohol content of 20 milligrams per 100 milliliters. However, Poland maintains a strict zero-tolerance policy towards cannabis, meaning any trace of THC in a driver’s system could lead to severe consequences.
According to Polski Obserwator, a person caught with cannabis in their car by Polish police could face imprisonment. Lawyer Bernard Długosz explains that THC levels below 2.5 nanograms per milliliter are considered an administrative offense, resulting in a fine of at least 600 euros and a driving ban of six months to three years. Higher THC levels, exceeding 2.5 nanograms per milliliter, constitute a criminal offense, carrying a hefty fine, up to two years of imprisonment, and a driving ban ranging from three to fifteen years. Polish police rigorously test for THC levels, and a positive result from a quick test will lead to a detailed blood test and subsequent legal action based on the results.
Meanwhile, in the Philippines, there is a growing movement towards legalizing medical marijuana. House Bill 10439, which passed the House of Representatives in July, seeks to legalize medical marijuana for various health conditions. The bill now awaits approval from the Senate, where a similar bill, Senate Bill 2573, is under debate. Despite facing challenges and opposition from some lawmakers, the bill’s proponents emphasize its potential as a treatment option for debilitating diseases, particularly highlighting the non-addictive properties of CBD.
Sri Lanka, on the other hand, is actively pursuing investment opportunities in the cannabis industry. The government’s cannabis investment plan has already garnered 30 applications for projects focused on medical marijuana cultivation and export. These projects will be located in Mirigama and Kandy, with plans for oil extraction as a value-added product. This development follows the government’s approval in February of a proposal allowing the cultivation and export of medical cannabis.
The contrasting stances on cannabis in these countries reflect the evolving global landscape surrounding this controversial plant. While some countries are moving towards legalization or regulated use, others continue to uphold strict prohibition laws. The future of cannabis remains uncertain, with ongoing debates about its potential benefits and risks, particularly in the context of public health and safety.
